• 1. Synthesis of ferromagnetic polymer coated nanoparticles on multi-gram scale with tunable particle size
  Mathew M. Bull,Woo Jin Chung,Sarah R. Anderson,Su-jeong Kim,In-Bo Shim,Hyun-jong Paik,Jeffrey Pyun J. Mater. Chem. 2010 20 6023

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids Phenylpropanoic acids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Professional Introduction to 2-4-(Bromomethyl)phenylpropionic Acid (CAS No. 111128-12-2)

2-4-(Bromomethyl)phenylpropionic Acid, identified by the Chemical Abstracts Service Number (CAS No.) 111128-12-2, is a versatile organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound, characterized by its bromomethyl functional group and phenylpropionic acid backbone, serves as a crucial intermediate in the synthesis of various biologically active molecules. Its unique structural features make it particularly valuable for the development of novel therapeutic agents, particularly in the realm of drug discovery and medicinal chemistry.

The bromomethyl group in 2-4-(Bromomethyl)phenylpropionic Acid is a highly reactive moiety that facilitates nucleophilic substitution reactions, enabling the facile introduction of diverse functional groups. This reactivity has been leveraged in synthetic protocols to construct complex molecular architectures, including heterocyclic compounds and peptidomimetics. The phenylpropionic acid moiety, on the other hand, contributes to the compound's solubility and metabolic stability, making it an attractive candidate for further derivatization.

In recent years, 2-4-(Bromomethyl)phenylpropionic Acid has been extensively studied for its potential applications in the development of anti-inflammatory and analgesic agents. Researchers have demonstrated its utility in synthesizing nonsteroidal anti-inflammatory drugs (NSAIDs) with enhanced efficacy and reduced side effects. The bromomethyl group allows for selective functionalization, enabling the introduction of pharmacophores that modulate inflammatory pathways. Preliminary studies have shown promising results in preclinical models, suggesting its therapeutic potential.

Moreover, 2-4-(Bromomethyl)phenylpropionic Acid has found applications in the synthesis of protease inhibitors, which are critical for treating various diseases, including cancer and viral infections. The phenylpropionic acid backbone provides a stable scaffold for designing molecules that can inhibit specific proteases involved in disease progression. By leveraging the reactivity of the bromomethyl group, researchers have been able to develop potent inhibitors with high selectivity and affinity.

The compound's versatility extends to its role in material science and polymer chemistry. The bromomethyl group can be used to introduce cross-linking agents, enhancing the mechanical properties of polymers. Additionally, 2-4-(Bromomethyl)phenylpropionic Acid has been explored as a monomer in the synthesis of novel polymers with tailored properties for applications in coatings, adhesives, and biomedical materials.

Recent advancements in green chemistry have also highlighted the importance of 2-4-(Bromomethyl)phenylpropionic Acid as a sustainable building block. Researchers have developed environmentally friendly synthetic routes that minimize waste and reduce energy consumption. These methods align with the growing emphasis on sustainable practices in pharmaceutical manufacturing and chemical synthesis.

The pharmacological profile of 2-4-(Bromomethyl)phenylpropionic Acid continues to be an area of active investigation. Studies have revealed its potential as a precursor for neuroprotective agents, which are essential for treating neurodegenerative diseases such as Alzheimer's and Parkinson's. The compound's ability to undergo selective functionalization has allowed researchers to design molecules that target specific neurotransmitter systems, offering new avenues for therapeutic intervention.

In conclusion, 2-4-(Bromomethyl)phenylpropionic Acid (CAS No. 111128-12-2) is a multifaceted compound with significant implications across multiple domains of chemistry and medicine. Its unique structural features and reactivity make it an invaluable tool for synthetic chemists and pharmaceutical researchers alike. As our understanding of its properties continues to evolve, so too will its applications in drug discovery, material science, and sustainable chemistry.

• 13737-36-5(4-(Bromomethyl)phenylacetic acid)
• 98986-08-4(ethyl 2-[4-(bromomethyl)phenyl]propanoate)
• 7233-85-4(2-phenylpropanoate)
• 124709-72-4(Benzeneacetic acid, -alpha-,4-dimethyl-, (-alpha-S)- (9CI))
• 2328-24-7( )
• 3585-52-2(2-(4-ethylphenyl)propanoic acid)
• 24311-92-0(2-(4-Methylphenyl)propanoate)
• 3585-48-6((R,S)-2-(4'-isopropylphenyl) propionic acid)
• 118647-53-3(2-[3-(bromomethyl)phenyl]acetic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)